Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Blocklisting Interim Review

10 Sep 2010 07:00

RNS Number : 4567S
BrainJuicer Group PLC
10 September 2010
 



10 September 2010

 

BrainJuicer Group PLC

 

Block Listing Interim Review and Total Voting Rights

 

 

BrainJuicer Group PLC today announces the following Interim Review on its Blocklisting Scheme: 

 

Dated: 10 September 2010

 

1. Name of the company:

BrainJuicer Group PLC

 

2. Name of the scheme:

BrainJuicer Group PLC Employee Share Option Scheme

 

3. Period of return (from/to):

10 March 2010 - 9 September 2010

 

4. Number and class of securities not issued under the scheme from previous review:

156,873 ordinary shares of 1p each

 

5. The amount by which the scheme has been increased during the period:

500,000 ordinary shares of 1p each

 

6. Number of securities issued under the scheme during the period:

180,469 ordinary shares of 1p each

 

7. Balance under the scheme of securities not yet issued at the end of the period:

476,404 ordinary shares of 1p each

 

8. Number and class of securities originally admitted and the date of admission:

12,550,613 ordinary shares of 1p each on 5 December 2006

 

9. Number and class of securities in issue as at the date of this announcement:

The Company has 13,113,114 ordinary shares of 1p each in issue.

 

 

Treasury Shares

 

On 22 April 2010, the Company bought back 650,000 shares in order to satisfy the Company's Long Term Incentive Plan ("LTIP"), which is in the process of being established. The Buy-Back Shares are initially being held in Treasury and will subsequently be transferred to the Employee Benefit Trust ("EBT"). Following the buy back the Company has 660,000 ordinary shares remaining in Treasury.

 

Total Voting Rights

 

As stated above, the Company currently holds 660,000 ordinary shares in Treasury and therefore the total number of ordinary shares with voting rights is 12,453,114.

 

The above figure of 12,453,114 ordinary shares may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.

 

 

Contact name and telephone number:

James Geddes, Chief Financial Officer

Tel: +44 (0)20 7043 1000 

 

Canaccord Genuity Limited

Mark Williams / Henry Fitzgerald-O'Connor

Tel: +44 (0)20 7050 6500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRLLFSEATIAIII
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.